Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-28

FDA Approved: TRIAZOLAM — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved TRIAZOLAM under an Original Application, authorizing the marketing of a generic triazolam product by Zydus Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIAZOLAM (TRIAZOLAM)

Snippet

ORIG AP for TRIAZOLAM (TRIAZOLAM)